Biomed Grants Race Post-Shutdown: NIH's Urgent Hideaway
Published Date: 11/28/2025
Notice
Summary
The NIH’s Center for Scientific Review is holding a closed virtual meeting on December 17, 2025, to review important biomedical research grant applications. This meeting was delayed due to a government shutdown but is now urgent to keep funding on track for key health projects. Scientists and researchers waiting on NIH grants are the ones affected, with no direct cost changes but a tight timeline to keep research moving.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 1 costs, 1 mixed.
Urgent rescheduled NIH grant review
The NIH is holding a virtual grant review meeting on December 17, 2025 (9:00 a.m. to 6:00 p.m.) that was delayed by a 43-day government shutdown. Scientists and researchers waiting on NIH grant evaluations are affected because the meeting is urgent to allow timely funding recommendations, and the notice was published less than 15 days before the meeting. There are no direct cost changes stated, but the timeline to keep research funding on track is tight.
Meeting closed to public for privacy
The meeting on December 17, 2025 will be closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) because discussions could disclose confidential trade secrets, commercial property, patentable material, or personal information. That means the public cannot attend or observe the grant application reviews that day.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05673 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05527 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new gene-editing invention that can fix a rare genetic disease called ROSAH syndrome, which causes vision loss and other problems. Companies can license this technology to develop treatments that might restore vision and improve lives. Interested parties should act soon and be ready to sign a confidentiality agreement to get all the details.
Previous / Next Documents
Previous: 2025-21350 — Certain Liquid Crystal Display Devices, Components Thereof, and Products Containing the Same; Notice of Institution of Investigation
The U.S. International Trade Commission is launching an investigation into certain liquid crystal display (LCD) devices and their parts because some companies say these products break their patents. This affects businesses importing or selling these LCD products in the U.S., and could lead to import bans or sales stops soon. Keep an eye out—this could shake up the LCD market and impact money flow starting late 2025 or early 2026.
Next: 2025-21352 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding a closed virtual meeting on January 20, 2026, to review grant applications focused on improving vaccine effectiveness. These meetings are private to protect sensitive information like trade secrets and personal details. Scientists and researchers applying for grants should note this important review date, but no new costs or changes to funding are announced.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in